Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
EL Konrath, CS Passos, LC Klein-Júnior… - Journal of Pharmacy …, 2013 - academic.oup.com
Objectives The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of A lzheimer's disease
EL Konrath, C dos Santos Passos… - Journal of Pharmacy …, 2013 - infona.pl
Objectives The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown
of acetylcholine, is currently the main pharmacological strategy available for A lzheimer's …
of acetylcholine, is currently the main pharmacological strategy available for A lzheimer's …
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease.
EL Konrath, LC Klein Jr, AT Henriques - The Journal of Pharmacy …, 2013 - europepmc.org
Objectives The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of A lzheimer's disease
EL Konrath, CS Passos, LC Klein‐Júnior… - Journal of Pharmacy …, 2013 - Wiley Online Library
Objectives The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown
of acetylcholine, is currently the main pharmacological strategy available for A lzheimer's …
of acetylcholine, is currently the main pharmacological strategy available for A lzheimer's …
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease.
EL Konrath, CS Passos, LC Klein Júnior, AT Henriques - 2013 - cabidigitallibrary.org
Objectives: The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
[PDF][PDF] Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
EL Konrath, C dos Santos Passos, LC Klein-Júnior… - 2013 - academia.edu
Objectives The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease.
EL Konrath, CS Passos… - … of Pharmacy & …, 2013 - search.ebscohost.com
Objectives The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
EL Konrath, C dos Santos Passos… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Objectives The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …
of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's …